
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Haude, Michael, Erbel, Raimund, Erne, Paul, Verheye, Stefan, Degen, Hubertus, Böse, Dirk, Vermeersch, Paul, Wijnbergen, Inge, Weissman, Neil, Prati, Francesco, Waksman, Ron, Koolen, JacquesVolume:
381
Langue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(12)61765-6
Date:
March, 2013
Fichier:
PDF, 854 KB
english, 2013